Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
Critical Reviews™ in Therapeutic Drug Carrier Systems
IF: 2.9 5-Year IF: 3.72 SJR: 0.736 SNIP: 0.818 CiteScore™: 4.6

ISSN Print: 0743-4863
ISSN Online: 2162-660X

Volumes:
Volume 37, 2020 Volume 36, 2019 Volume 35, 2018 Volume 34, 2017 Volume 33, 2016 Volume 32, 2015 Volume 31, 2014 Volume 30, 2013 Volume 29, 2012 Volume 28, 2011 Volume 27, 2010 Volume 26, 2009 Volume 25, 2008 Volume 24, 2007 Volume 23, 2006 Volume 22, 2005 Volume 21, 2004 Volume 20, 2003 Volume 19, 2002 Volume 18, 2001 Volume 17, 2000 Volume 16, 1999 Volume 15, 1998 Volume 14, 1997 Volume 13, 1996 Volume 12, 1995

Critical Reviews™ in Therapeutic Drug Carrier Systems

DOI: 10.1615/CritRevTherDrugCarrierSyst.v17.i4.20
49 pages

Polysaccharides for Vascular Cell Targeting

Catherine Blondin
Current address: Institut Pasteur, Unite d'lmmuno-Allergie, 25 rue du Dr Roux, 75015 Paris, France
Isabelle Bataille
Laboratoire de Recherches sur les Macromolecules, Institut Galilee, Universite Paris 13, CNRS UMR 7540, IFREMER URM2, 99 Av. J.B. Clement, 93430 Villetaneuse, France
Didier Letourneur
Laboratoire de Recherches sur les Macromolecules, Institut Galilee, Universite Paris 13, CNRS UMR 7540, IFREMER URM2, 99 Av. J.B. Clement, 93430 Villetaneuse, France

ABSTRACT

Carbohydrate structures are involved in numerous biological activities such as inflammation, and cell adhesion/migration/proliferation. This gives the rationale for the design of vascular targeted drug delivery systems bearing sugar moieties. For the imaging and treatment of vascular diseases, an overview is presented with polysaccharides targeting vascular components. After a general description of the vasculature and the main blood components, a special emphasis is placed on carbohydrate-based molecules, such as heparin/heparan sulfate, and carbohydrate-binding proteins, such as selectins found in the vascular system. The methods using heparin and heparin analogs in delivery systems applied to vascular components are then described.


Articles with similar content:

Biopolymers as Transdermal Drug Delivery Systems in Dermatology Therapy
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.27, 2010, issue 2
M.A. Navya, K. H. Basavaraj, Siddaramaiah, George Johnsy, R. Rashmi
Advances in Buccal Drug Delivery
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.22, 2005, issue 3
Raj Birudaraj, Bhaskara R. Jasti, Xiaoling Li, Ravichandran Mahalingam
Recent Advances in Nanoparticle-Based Targeted Drug-Delivery Systems Against Cancer and Role of Tumor Microenvironment
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.34, 2017, issue 4
Usman Ali Ashfaq, Muhammad Zubair Yousaf, Erum Yasmeen, Muhammad Riaz
Design of Fatty Acid Conjugates for Dermal Delivery and Topical Therapeutics
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.23, 2006, issue 1
Shimon Ben-Shabat, Amnon Sintov
Stem Cell Therapy for Diabetes Mellitus: Recent Progress and Hurdles
Critical Reviews™ in Eukaryotic Gene Expression, Vol.29, 2019, issue 5
Ammara Saleem, Uzma Saleem, Mohammad Saleem, Muhammad Furqan Akhtar, Sara Zahid, Sammia Gul Niazi, Shakila Sabir, Muhammad Naeem